Oct 28, 2010, 9:32 PM EST
Some breaking news here from Michael S. Schmidt of the New York Times.
Giants outfielder Jose Guillen was left off San Francisco’s postseason roster this month not because of his poor play, but because he is being investigated currently for ties to performance-enhancing drugs.
According to Schmidt’s report, Guillen had packages of human growth hormone (HGH) sent to an address that is registered to his wife in the Bay Area during the 2010 season. Major League Baseball immediately opened an investigation and recommended to the Giants that Guillen be left off the club’s postseason roster. The Giants complied and the investigation goes on.
Few people have agreed to comment on the story and Guillen should be viewed as innocent until proven guilty, but it wouldn’t be the first time that the veteran outfielder has been linked to performance-enhancers. The San Francisco Chronicle discovered in 2007 that Guillen bought more than $19,000 worth of HGH between 2002 and 2005.
All of this could lead to a 50-game suspension for the 34-year-old impending free agent. He slugged 19 home runs and tallied 77 RBI in 524 at-bats this past season, but he no longer plays good defense and it’s highly probable that Guillen won’t be available for the fist few months of 2011. It’s going to be tough for him to find a contract before the start of next year’s regular season.
- Matt Kemp remains “in play” for the Red Sox 43
- Robinson Cano “didn’t want to play” for Joe Girardi 94
- Report: Yankees have agreed to a three-year deal with Carlos Beltran 121
- Mike Napoli agrees to two-year, $32 million deal with Red Sox 36
- Curtis Granderson leaves Yankees for Mets (and $60 million) 68
- Robinson Cano agrees to $240 million deal with Mariners (260)
- Yankees agree to seven-year, $153M contract with free agent outfielder Jacoby Ellsbury (160)
- Report: Mariners willing to offer Robinson Cano a 10-year, $240 million deal (143)
- Report: Yankees have agreed to a three-year deal with Carlos Beltran (122)
- Brett Gardner is drawing “significant” trade interest (108)